SAGE Publishing provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →01Impact factor
Impact factor of Therapeutic Advances in Musculoskeletal Disease (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Therapeutic Advances in Musculoskeletal Disease published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Rheumatologyrank 11 of 62 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Therapeutic Advances in Musculoskeletal Disease
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Therapeutic Advances in Musculoskeletal Disease is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$2,650.
Is your paper a fit for Therapeutic Advances in Musculoskeletal Disease?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Rheumatology accept papers in a median of 45 days.
- Rheumatology International 45 days
- JCR Journal of Clinical Rheumatology 68 days
- Rheumatology and Therapy 71 days
APC waivers and discounts for Therapeutic Advances in Musculoskeletal Disease APC about US$2,650
SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Authors in 82 countries get a full waiver.
02Retractions
Retractions and research integrity at Therapeutic Advances in Musculoskeletal Disease
Most common reasons (a retraction can have several):
Therapeutic Advances in Musculoskeletal Disease has 1 retracted paper on record, the latest in Jul 2023. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
03Funders
Who funds research published in Therapeutic Advances in Musculoskeletal Disease
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Therapeutic Advances in Musculoskeletal Disease
- ISSN
- 1759-720X
- eISSN
- 1759-7218
- Publisher
- SAGE Publishing all its journals →
- Subjects
- Rheumatology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
- Web of Science Master Journal List
- SCImago Journal Rank
- ISSN Portal (ISSN 1759-720X)
- DOAJ (Directory of Open Access Journals)
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Therapeutic Advances in Musculoskeletal Disease
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Therapeutic Advances in Musculoskeletal Disease accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. SAGE Publishing offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Plan the fee. Therapeutic Advances in Musculoskeletal Disease is fully open access, with an article fee of about US$2,650 after acceptance. See whether your author team qualifies for a waiver with the free APC waiver checker.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Therapeutic Advances in Musculoskeletal Disease
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Therapeutic Advances in Musculoskeletal Disease, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Rheumatology journals with a similar impact factor*
The journals next to Therapeutic Advances in Musculoskeletal Disease when the 58 journals of Rheumatology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 7 | Arthritis & Rheumatology | 4.23 | SCIE | Subscription |
| 8 | Current Opinion in Rheumatology | 3.97 | SCIE | Subscription |
| 9 | Rheumatology International | 3.80 | SCIE | Subscription |
| 10 | Seminars in Arthritis and Rheumatism | 3.63 | SCIE | Subscription |
| 12 | Rheumatology and Therapy | 3.53 | SCIE | Fully open access |
| 13 | Lupus Science & Medicine | 3.36 | SCIE | Fully open access |
| 14 | Arthritis Care & Research | 3.13 | SCIE | Subscription |
| 15 | BMC Musculoskeletal Disorders | 3.09 | SCIE | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Therapeutic Advances in Musculoskeletal Disease right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Therapeutic Advances in Musculoskeletal Disease?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Therapeutic Advances in Musculoskeletal Disease is 3.60: papers it published in the two previous years were cited 3.60 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Therapeutic Advances in Musculoskeletal Disease?
The h-index of Therapeutic Advances in Musculoskeletal Disease is 69 (October 2026): 69 of its papers have each been cited at least 69 times. Its i10-index is 497.
What is the APC of Therapeutic Advances in Musculoskeletal Disease?
The listed article processing charge (APC) is about US$2,650 for Therapeutic Advances in Musculoskeletal Disease, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Therapeutic Advances in Musculoskeletal Disease?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Therapeutic Advances in Musculoskeletal Disease is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Therapeutic Advances in Musculoskeletal Disease indexed in Scopus?
Yes. Therapeutic Advances in Musculoskeletal Disease appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Therapeutic Advances in Musculoskeletal Disease an SCIE journal?
Yes. Therapeutic Advances in Musculoskeletal Disease is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Therapeutic Advances in Musculoskeletal Disease in Journal Citation Reports (JCR)?
Yes. Therapeutic Advances in Musculoskeletal Disease is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Therapeutic Advances in Musculoskeletal Disease offer an APC waiver?
Therapeutic Advances in Musculoskeletal Disease follows the policy of SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has Therapeutic Advances in Musculoskeletal Disease retracted papers?
Yes. 1 retracted paper are on record for Therapeutic Advances in Musculoskeletal Disease, 1 of them in the last 10 years; the most common reasons are concerns/issues about image, duplication of/in image, error in image. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Therapeutic Advances in Musculoskeletal Disease?
51% of 153 recent research articles in Therapeutic Advances in Musculoskeletal Disease name a funder; the funders named most often are National Natural Science Foundation of China, Pfizer, Novartis.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Alloys and Compounds
- International Journal of Biological Macromolecules
- British Journal of Surgery
- Journal of Molecular Structure
- Biochemistry
- Frontiers in Microbiology
- Medicine
- Energy
- Zootaxa
- Tetrahedron Letters
- Chemical Engineering Journal
- Analyst
- Electronics Letters
- Journal of Organometallic Chemistry
Browse all journals: indexing, impact factor and reviewer comments →